Vimarsana
Biggest News Aggregation in the World

Page 28 - Mobile Opera News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mobile Opera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mobile Opera Today - Breaking & Trending Today

Chemicals found in hair products increase viability of breast cancer cells in Black women - Vimarsana News

Chemicals found in hair products increase viability of breast cancer cells in Black women

ATLANTA — Parabens, a class of endocrine-disrupting chemicals widely found in hair and personal care products, promote viability and gene expression of a breast cancer cell line in Black women, according to data presented at ENDO 2022. Researchers evaluated the effects of three types of parabens in the HCC1500 breast cancer cell line, which is typically found in Black women of West African

Source: healio.com
Acupuncture benefits patients with radiation-induced xerostomia - Vimarsana News

Acupuncture benefits patients with radiation-induced xerostomia

Acupuncture benefitted patients with head and neck cancer who had radiation-induced xerostomia, according to study results presented at ASCO Annual Meeting.The randomized phase 3 WF-97115 trial included 258 patients.

Source: healio.com
Top in GI: Restrictive diets in irritable bowel syndrome; alcohol use amid COVID-19 - Vimarsana News

Top in GI: Restrictive diets in irritable bowel syndrome; alcohol use amid COVID-19

A recent study showed that restrictive diets were more effective than optimized medical treatment alone in reducing symptoms of irritable bowel syndrome.

Source: healio.com
Future type 1 diabetes therapies, women's CV health among plenary sessions at ENDO 2022 - Vimarsana News

Future type 1 diabetes therapies, women's CV health among plenary sessions at ENDO 2022

Experts from across the field of endocrinology will gather in Atlanta beginning Saturday for the first in-person Endocrine Society annual meeting in 3 years. ENDO 2022 will kick off Saturday and continue through Tuesday at the Georgia World Congress Center in Atlanta. This year’s meeting will have a hybrid format, with more than 100 sessions livestreamed to a virtual platform for attendees

Source: healio.com
Relatlimab plus nivolumab confers benefit across key subgroups in advanced melanoma - Vimarsana News

Relatlimab plus nivolumab confers benefit across key subgroups in advanced melanoma

CHICAGO —Adding relatlimab to nivolumab improved PFS, OS and objective response rates across key subgroups of patients with previously untreated metastatic or unresectable melanoma, according to a study presented at ASCO Annual Meeting.The results showed superiority of nivolumab and relatlimab-rmbw (Opdualag, Bristol Myers Squibb) over single-agent nivolumab (Opdivo, Bristol Myers Squibb),

Source: healio.com